CSS® Encapsulation Equipment
EncapSure™Precision-Made for Advanced Drug Delivery – Available Q1 2027
Likarda’s proprietary Core Shell Spherification® (CSS®) technology is now being engineered for in-house use—empowering pharmaceutical, biotech, and cell therapy teams to encapsulate their own products with precision and scalability.
Launching in Q1 2027, EncapSure™ is Likarda’s closed CSS® encapsulation system designed to enable standardized, scalable microbead production. The platform integrates automated microbead generation, modular fluid control, combined rinsing and crosslinking workflows, and in-process quality control within a fully enclosed, GMP-ready system designed to support preclinical, clinical, and commercial applications.
Why EncapSure™?
Standardized & Scalable
From early-stage R&D to commercial manufacturing, the CSS® system adapts to your throughput needs.
Automated Workflow
Reduce manual variability with enclosed fluidics, programmable batch parameters, and rinse automation.
Compatible Inputs
Designed for cells, biologics, peptides, and small molecules in aqueous or lightly viscous solutions.
Versatile Output
Supports live encapsulated products for just-in-time delivery and cryopreserved formats for long-term storage.
Rapid Setup
Ready to run in under 60 minutes with encapsulation runs completed in as little as 30 minutes
Key Use Cases
- In-house preclinical testing of therapeutics
- GMP manufacturing of injectable cell therapies
- Extended-release formulations for biologics and peptides
- Encapsulation of cryopreserved or fresh cells for global logistics
Prepare for EncapSure™
Contact us to learn more about equipment availability, installation timelines, and early adopter pricing.